Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe RheumatoId Arthritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07836660
What this trial is testing

IBI355 in Participants With Moderate-to-Severe Sjögren's Disease

Who this might be right for
Sjögren's Disease
Innovent Biologics (Suzhou) Co. Ltd. 198
Large-scale testing (Phase 3)Study completedNCT02760368
What this trial is testing

Evaluation of the Effectiveness and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease

Who this might be right for
Rheumatoid Arthritis
R-Pharm International, LLC 428
Large-scale testing (Phase 3)Study completedNCT01347983
What this trial is testing

Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Chugai Pharma Taiwan 72
Testing effectiveness (Phase 2)Study completedNCT01649999
What this trial is testing

Evaluate the Efficacy and Safety of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects

Who this might be right for
Arthritis, Rheumatoid
Astellas Pharma Inc 281
Large-scale testing (Phase 3)Study completedNCT01662063
What this trial is testing

A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 218
Early research (Phase 1)Looking for participantsNCT07041099
What this trial is testing

CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

Who this might be right for
SjögrenSjogren DiseaseSjogren's Syndrome
Cullinan Therapeutics Inc. 36
Early research (Phase 1)Study completedNCT04246762
What this trial is testing

Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharmacokinetics of Substrates for CYP1A2, CYP2C9, CYP2C19 and CYP3A4

Who this might be right for
Rheumatoid Arthritis
R-Pharm International, LLC 17
Large-scale testing (Phase 3)Ended earlyNCT03970837
What this trial is testing

Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 1,764
Post-approval studies (Phase 4)Study completedNCT05660655
What this trial is testing

Efficacy and Safety of Baricitinib for the Treatment of Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 94
Testing effectiveness (Phase 2)Study completedNCT04247815
What this trial is testing

Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA

Who this might be right for
Rheumatoid Arthritis
Aclaris Therapeutics, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT02969044
What this trial is testing

Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate

Who this might be right for
Rheumatoid Arthritis
Pfizer 70
Large-scale testing (Phase 3)Study completedNCT02480153
What this trial is testing

PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).

Who this might be right for
Rheumatoid Arthritis
Pfizer 597
Post-approval studies (Phase 4)Study completedNCT01331837
What this trial is testing

Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 3,080
Post-approval studies (Phase 4)UnknownNCT05803135
What this trial is testing

Iguratimod Combined With Tofacitinib in the Treatment of Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Nanfang Hospital, Southern Medical University 138
Large-scale testing (Phase 3)Study completedNCT04230213
What this trial is testing

A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Pfizer 455
Large-scale testing (Phase 3)Study completedNCT00109408
What this trial is testing

Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 673
Testing effectiveness (Phase 2)Study completedNCT03355872
What this trial is testing

A Randomised, Double-blind, Phase I/II Study to Evaluate the PK, PD, Safety, and Efficacy Between HLX01 and Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis and Inadequate Response to Treatment With DMARDs

Who this might be right for
Rheumatoid Arthritis
Shanghai Henlius Biotech 194
Large-scale testing (Phase 3)Ended earlyNCT01682512
What this trial is testing

Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Boehringer Ingelheim 294
Testing effectiveness (Phase 2)Study completedNCT07349420
What this trial is testing

EF-M2 (Immutalon) Multiple Ascending Dose Study in Moderate-to-Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
S.LAB (SOLOWAYS) 48
Large-scale testing (Phase 3)Study completedNCT02937701
What this trial is testing

Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab

Who this might be right for
Arthritis, Rheumatoid
Amgen 558
Next Page